AVR 1.11% $18.20 anteris technologies ltd

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-179

  1. 7,961 Posts.
    lightbulb Created with Sketch. 502
    Definitely not wesso

    I'm always open

    I cant make the company hold the vaccine div as you are aware so I'll cop what comes

    I'd be happy to derisk spinning out the HSV but I'd prefer to keep HPV

    HPV is where I think we have a better chance of success

    Interesting this collaboration though

    It's almost like they've made it up on their own

    Maybe it is to be used to obtain funding?
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$18.20
Change
0.200(1.11%)
Mkt cap ! $349.8M
Open High Low Value Volume
$18.00 $18.20 $17.65 $78.15K 4.366K

Buyers (Bids)

No. Vol. Price($)
1 619 $17.86
 

Sellers (Offers)

Price($) Vol. No.
$18.20 146 1
View Market Depth
Last trade - 16.10pm 08/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.